ARTICLE
13 January 2021

Healthcare Transactions: Year In Review

BB
Bass, Berry & Sims

Contributor

Bass, Berry & Sims is a national law firm with nearly 350 attorneys dedicated to delivering exceptional service to numerous publicly traded companies and Fortune 500 businesses in significant litigation and investigations, complex business transactions, and international regulatory matters. For more than 100 years, our people have served as true partners to clients, working seamlessly across substantive practice disciplines, industries and geographies to deliver highly-effective legal advice and innovative, business-focused solutions. For more information, visit www.bassberry.com.
2020 was a tumultuous year for the healthcare industry, which continues to confront the effects of the COVID-19 pandemic.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

2020 was a tumultuous year for the healthcare industry, which continues to confront the effects of the COVID-19 pandemic. Despite these unprecedented and unpredictable times, healthcare merger and acquisition (M&A) activity did not decline as sharply as many predicted, even rebounding in the second half of the year.

Download Healthcare Transactions: Year in Review for a breakdown of M&A activity and drivers in 2020 in the following hot sectors:

  • Hospitals
  • Post-Acute Care – Home Health & Hospice and Personal Care Services
  • Physician Practice Management
  • Ambulatory Surgery Centers (ASCs)
  • Behavioral Health
  • Pharmacy
  • Managed Care
  • Health Information Technology

To view the full article please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

ARTICLE
13 January 2021

Healthcare Transactions: Year In Review

United States Food, Drugs, Healthcare, Life Sciences

Contributor

Bass, Berry & Sims is a national law firm with nearly 350 attorneys dedicated to delivering exceptional service to numerous publicly traded companies and Fortune 500 businesses in significant litigation and investigations, complex business transactions, and international regulatory matters. For more than 100 years, our people have served as true partners to clients, working seamlessly across substantive practice disciplines, industries and geographies to deliver highly-effective legal advice and innovative, business-focused solutions. For more information, visit www.bassberry.com.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More